通过人工智能推进miRNA癌症研究:从生物标志物发现到治疗向
Raghu Aswathy1, Varghese Angel Chalos1, Kanagaraj Suganya1
1Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu, 641043, India.
Medical oncology (Northwood, London, England)
|December 17, 2024
概括
人工智能 (AI) 和机器学习正在彻底改变微RNA (miRNA) 癌症研究. 这些技术有效地分析复杂的数据,以识别癌症生物标志物并改进诊断和治疗策略.
科学领域:
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键转录后调节者,在癌症中具有显著的治疗潜力.
- RNA测序的进步使得用于诊断和预后的miRNA的全面探索成为可能,但数据分析仍然具有挑战性.
- 人工智能 (AI) 为从复杂的生物数据集中提取见解提供了强大的工具.
研究的目的:
- 审查机器学习 (ML) 技术在各种癌症中的微RNA研究中的应用.
- 突出AI在识别miRNA生物标记物,阐明目标和预测预后结果方面的作用.
- 引导研究人员利用人工智能加速癌症诊断和治疗.
主要方法:
- 关于机器学习应用在miRNA癌症研究中的当前文献的综述.
- 分析AI在生物标志物发现,目标识别和预后建模中的作用.
- 讨论人工智能驱动的miRNA数据库及其在癌症研究中的有用性.
主要成果:
- 机器学习有效地识别关键的miRNAs,并开发各种癌症的预后模型.
- 人工智能集成有助于创建用于mRNA和基因标识的全面miRNA数据库.
- 人工智能增强了癌症研究,诊断和治疗中miRNAs的理解和应用.
结论:
- 人工智能和机器学习技术对于克服miRNA研究中的数据分析挑战至关重要.
- 这些技术加速了miRNA生物标志物的发现,并改善了癌症的预后预测.
- 在miRNA研究中利用人工智能有望在癌症诊断和基于RNA的治疗中取得重大进展.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K


